SPRIM Global Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Consulting

Industry

Estimated Revenue & Valuation

  • SPRIM Global's estimated annual revenue is currently $8.3M per year.(i)
  • SPRIM Global's estimated revenue per employee is $176,000

Employee Data

  • SPRIM Global has 47 Employees.(i)
  • SPRIM Global grew their employee count by -2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.2M9228%N/AN/A
#2
$2.2M17-59%N/AN/A
#3
$5.3M3020%N/AN/A
#4
$8.1M467%N/AN/A
#5
$18.7M851%N/AN/A
#6
$13.9M704%N/AN/A
#7
$5.3M307%N/AN/A
#8
$23.1M10511%N/AN/A
#9
$12.1M617%N/AN/A
#10
$125.7M45711%N/AN/A
Add Company

SPRIM has more than 450 people in 17 offices across six continents. We focus on discovering and implementing new ideas to deliver better health. Large multi-national companies, startups, institutions, and governments around the world turn to us for help developing relevant, fresh and meaningful health innovations. From traditional categories like nutrition, cosmetics, personal care and pharmaceuticals to the new health frontier of digital-connected devices and algorithm-based diagnostics, we work to deliver winning health solutions and tangible commercial results. In 2017, SPRIM and Tikehau Capital launched TKS 1, a venture capital fund designed to support early-stage, healthcare tech companies. TKS 1 provides capital to innovative companies offering solutions that move science forward in the health sector, contribute to the transition from intervention to prediction, and enable life science companies globally to develop therapeutics faster and more economically.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$8.3M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SPRIM Global's People

NameTitleEmail/Phone
1
VP Stakeholder EngagementReveal Email/Phone
2
VP Quality managementReveal Email/Phone
3
Scientific Project ManagerReveal Email/Phone

SPRIM Global News

2022-04-19 - Emergen-C adds ashwagandha and apple cider vinegar to ...

According to a white paper by Sprim?, the healthcare consulting agency found ... According to Grandview Research, the global immune health...

2022-03-30 - Blade Therapeutics Announces Feedback from FDA on End-of ...

... Blade plans to advance cudetaxestat into a 26-week global phase 2 ... the background and expertise of SPRIM Global Investments, a global...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.2M474%N/A
#2
$5.5M472%N/A
#3
$3.5M47-11%N/A
#4
$10.2M474%N/A
#5
$5.5M477%N/A